[
  {
    "ts": "2025-10-10T15:47:25+00:00",
    "headline": "Next medicine deal after Pfizer? Analysts, shares point to AstraZeneca, Eli Lilly",
    "summary": "By Bhanvi Satija and Maggie Fick LONDON (Reuters) -Wall Street is looking to U.S. drugmaker Eli Lilly and Anglo-Swedish rival AstraZeneca as the potential next in line after Pfizer struck a deal with",
    "url": "https://finance.yahoo.com/news/next-medicine-deal-pfizer-analysts-154725765.html",
    "source": "Reuters",
    "provider": "yfinance",
    "raw": {
      "id": "e5bf718e-6bac-3c86-b376-03e4a0af73e4",
      "content": {
        "id": "e5bf718e-6bac-3c86-b376-03e4a0af73e4",
        "contentType": "STORY",
        "title": "Next medicine deal after Pfizer? Analysts, shares point to AstraZeneca, Eli Lilly",
        "description": "",
        "summary": "By Bhanvi Satija and Maggie Fick LONDON (Reuters) -Wall Street is looking to U.S. drugmaker Eli Lilly and Anglo-Swedish rival AstraZeneca as the potential next in line after Pfizer struck a deal with",
        "pubDate": "2025-10-10T15:47:25Z",
        "displayTime": "2025-10-10T15:47:25Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/reuters.com/21736555fa2542a359a019bfde739fbb",
          "originalWidth": 800,
          "originalHeight": 533,
          "caption": "FILE PHOTO: The Pfizer logo is pictured on their headquarters building in the Manhattan borough of New York City, New York, U.S., November 9, 2020. REUTERS/Carlo Allegri/File Photo",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ZC_4u8KKl6ge5b9LszTFog--~B/aD01MzM7dz04MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/reuters.com/21736555fa2542a359a019bfde739fbb.cf.webp",
              "width": 800,
              "height": 533,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/.cqdgPcBT28.iZJmhZaOKg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/reuters.com/21736555fa2542a359a019bfde739fbb.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Reuters",
          "url": "https://www.reuters.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/next-medicine-deal-pfizer-analysts-154725765.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/next-medicine-deal-pfizer-analysts-154725765.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "AZN.L"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "MRK"
            },
            {
              "symbol": "ABBV"
            },
            {
              "symbol": "REGN"
            },
            {
              "symbol": "BMY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]